Search Results for “” – Page 18 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes Change patient management Observational

236 Publications found

Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?

b

Oncotarget

February 6, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach.

b

The oncologist

February 1, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Precision oncology using a clinician-directed, tailored approach to molecular profiling.

b

Asia-Pacific journal of clinical oncology

February 1, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.

b

Oncotarget

January 19, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study.

b

JCO precision oncology

January 1, 2018

p Cancer

c Change patient management Clinical outcomes Economics Observational
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.

b

JCO precision oncology

January 1, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities.

b

Clinical lung cancer

November 1, 2017

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
Implementation and utilization of the molecular tumor board to guide precision medicine.

b

Oncotarget

August 22, 2017

p Cancer

c Change patient management Clinical outcomes Observational
Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.

b

Inflammatory bowel diseases

July 1, 2017

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational
Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.

b

Oncotarget

June 13, 2017

p Cancer

c Change patient management Clinical outcomes Observational